Silexion Therapeutics

Advertisement

cGxPJobs Banner

.Clinical Bio-Pharma

Silexion’s SIL204 Shows Preclinical Promise in Pancreatic Cancer

GRAND CAYMAN, Cayman Islands, Sept. 11, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company developing RNA...

By cGxPwire Editor
September 12, 2025

Read More

Advertisement

cGxPJobs

Directory